Efficacy, tolerance, and pharmacokinetics of once daily tobramycin for pseudomonas exacerbations in cystic fibrosis

OBJECTIVE—To compare once daily with thrice daily tobramycin for treatment of Pseudomonas aeruginosa infection in patients with cystic fibrosis.
DESIGN—22 patients with cystic fibrosis, mean (SD) age 11 (3.4) years (range 5.6-19.3), with pulmonary pseudomonas exacerbations were randomly assigned to...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Vic, P, Ategbo, S, Turck, D, Husson, M, Launay, V, Loeuille, G, Sardet, A, Deschildre, A, Druon, D, Arrouet-Lagande, C
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Group 1998
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1717599/
https://ncbi.nlm.nih.gov/pubmed/9713009
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados